US Stock MarketDetailed Quotes

LCTX Lineage Cell Therapeutics

Watchlist
  • 0.989
  • +0.059+6.32%
Close May 30 16:00 ET
186.71MMarket Cap-7606P/E (TTM)

Lineage Cell Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
48.56%-5.78M
-2,797.45%-28.57M
27.51%-6.02M
8.08%-5.04M
11.24%-6.27M
-151.32%-11.24M
104.49%1.06M
-41.38%-8.3M
-13.04%-5.48M
-30.39%-7.06M
Net income from continuing operations
-48.91%-6.56M
18.50%-21.48M
25.90%-4.71M
-17.04%-7.16M
23.28%-5.2M
37.91%-4.4M
39.10%-26.35M
78.20%-6.36M
21.95%-6.12M
-41.41%-6.78M
Operating gains losses
-11.53%376K
-81.65%776K
-1,290.74%-1.29M
-47.82%1.05M
-74.00%586K
391.10%425K
151.00%4.23M
105.58%108K
548.55%2.01M
242.84%2.25M
Depreciation and amortization
2.34%175K
-4.81%692K
1.16%175K
-8.81%176K
-7.10%170K
-3.93%171K
-16.72%727K
-9.42%173K
-3.02%193K
-7.11%183K
Deferred tax
--0
---1.8M
--0
--0
--0
---1.8M
--0
--0
--0
--0
Other non cash items
96.93%-10K
-9.70%-588K
116.86%59K
---131K
---190K
---326K
-348.15%-536K
-2,600.00%-350K
----
----
Change In working capital
85.34%-929K
-157.76%-10.8M
53.62%-1.31M
85.56%-134K
35.19%-3.02M
-123.36%-6.34M
-11.34%18.7M
-113.31%-2.83M
-241.46%-928K
-1,028.49%-4.66M
-Change in receivables
603.16%668K
-100.89%-446K
-382.41%-305K
-93.68%6K
-15.24%-242K
-99.81%95K
5,970.95%50.31M
114.34%108K
-61.85%95K
3.67%-210K
-Change in prepaid assets
123.02%195K
-193.72%-418K
-567.61%-474K
523.38%326K
2,647.62%577K
-247.82%-847K
719.44%446K
-106.14%-71K
93.90%-77K
-83.33%21K
-Change in payables and accrued expense
83.42%-574K
87.73%-2.3M
202.83%1.16M
-70.73%485K
-47.08%-478K
81.68%-3.46M
-186.40%-18.7M
-105.30%-1.13M
26.59%1.66M
-527.63%-325K
-Change in other working capital
42.57%-1.22M
42.75%-7.65M
2.53%-1.7M
63.47%-951K
30.60%-2.88M
56.40%-2.12M
-3,614.21%-13.35M
-311.11%-1.74M
-821.05%-2.6M
-900.58%-4.15M
Cash from discontinued investing activities
Operating cash flow
48.56%-5.78M
-2,797.45%-28.57M
27.51%-6.02M
8.08%-5.04M
11.24%-6.27M
-151.32%-11.24M
104.49%1.06M
-41.38%-8.3M
-13.04%-5.48M
-30.39%-7.06M
Investing cash flow
Cash flow from continuing investing activities
-100.25%-38K
200.63%46.45M
290.94%9.74M
105.19%2.12M
19,851.55%19.16M
33,634.78%15.43M
-573.67%-46.16M
-3,394.52%-5.1M
-60,067.65%-40.91M
15.65%-97K
Net PPE purchase and sale
79.79%-38K
-63.20%-674K
-668.75%-91K
51.40%-139K
-163.92%-256K
-308.70%-188K
-21.47%-413K
110.96%16K
-320.59%-286K
15.65%-97K
Net investment purchase and sale
--0
203.01%47.12M
292.13%9.83M
105.57%2.26M
--19.42M
--15.61M
---45.75M
---5.12M
---40.63M
--0
Cash from discontinued investing activities
Investing cash flow
-100.25%-38K
200.63%46.45M
290.94%9.74M
105.19%2.12M
19,851.55%19.16M
33,634.78%15.43M
-573.67%-46.16M
-3,394.52%-5.1M
-60,067.65%-40.91M
15.65%-97K
Financing cash flow
Cash flow from continuing financing activities
1,402,000.00%14.02M
293.57%6.42M
-110.66%-13K
-16.29%807K
16,954.55%5.63M
-99.81%1K
-95.58%1.63M
-87.21%122K
-74.08%964K
-99.71%33K
Net issuance payments of debt
0.00%-13K
-68.75%-54K
-44.44%-13K
-50.00%-12K
-128.57%-16K
-62.50%-13K
-60.00%-32K
-28.57%-9K
38.46%-8K
---7K
Net common stock issuance
37,975.68%14.01M
4,929.01%6.59M
--0
--836K
64,422.22%5.79M
-126.43%-37K
-99.57%131K
--0
--0
-100.11%-9K
Proceeds from stock option exercised by employees
158.82%132K
-94.63%88K
--0
-99.21%8K
-72.64%29K
-86.61%51K
-77.36%1.64M
-85.38%142K
9.66%1.01M
-97.08%106K
Net other financing activities
---112K
-87.74%-199K
--0
34.21%-25K
----
----
90.37%-106K
90.91%-11K
63.11%-38K
----
Cash from discontinued financing activities
Financing cash flow
1,402,000.00%14.02M
293.57%6.42M
-110.66%-13K
-16.29%807K
16,954.55%5.63M
-99.81%1K
-95.58%1.63M
-87.21%122K
-74.08%964K
-99.71%33K
Net cash flow
Beginning cash position
201.54%35.99M
-78.79%11.94M
26.50%32M
-51.73%34.45M
-79.62%16.02M
-78.79%11.94M
69.60%56.28M
-58.75%25.3M
14.15%71.36M
38.60%78.61M
Current changes in cash
95.94%8.2M
155.92%24.31M
127.93%3.71M
95.36%-2.11M
359.88%18.52M
-81.29%4.19M
-288.06%-43.47M
-162.25%-13.28M
-3,695.32%-45.43M
-223.65%-7.13M
Effect of exchange rate changes
30.00%-70K
71.36%-250K
461.54%282K
46.37%-340K
22.69%-92K
-138.10%-100K
-4,265.00%-873K
-657.14%-78K
-7,144.44%-634K
-421.62%-119K
End cash Position
175.40%44.12M
201.54%35.99M
201.54%35.99M
26.50%32M
-51.73%34.45M
-79.62%16.02M
-78.79%11.94M
-78.79%11.94M
-58.75%25.3M
14.15%71.36M
Free cash flow
49.07%-5.82M
-4,626.32%-29.24M
26.27%-6.11M
10.23%-5.18M
8.87%-6.52M
-152.29%-11.43M
102.70%646K
-37.68%-8.29M
-17.29%-5.77M
-29.43%-7.16M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 48.56%-5.78M-2,797.45%-28.57M27.51%-6.02M8.08%-5.04M11.24%-6.27M-151.32%-11.24M104.49%1.06M-41.38%-8.3M-13.04%-5.48M-30.39%-7.06M
Net income from continuing operations -48.91%-6.56M18.50%-21.48M25.90%-4.71M-17.04%-7.16M23.28%-5.2M37.91%-4.4M39.10%-26.35M78.20%-6.36M21.95%-6.12M-41.41%-6.78M
Operating gains losses -11.53%376K-81.65%776K-1,290.74%-1.29M-47.82%1.05M-74.00%586K391.10%425K151.00%4.23M105.58%108K548.55%2.01M242.84%2.25M
Depreciation and amortization 2.34%175K-4.81%692K1.16%175K-8.81%176K-7.10%170K-3.93%171K-16.72%727K-9.42%173K-3.02%193K-7.11%183K
Deferred tax --0---1.8M--0--0--0---1.8M--0--0--0--0
Other non cash items 96.93%-10K-9.70%-588K116.86%59K---131K---190K---326K-348.15%-536K-2,600.00%-350K--------
Change In working capital 85.34%-929K-157.76%-10.8M53.62%-1.31M85.56%-134K35.19%-3.02M-123.36%-6.34M-11.34%18.7M-113.31%-2.83M-241.46%-928K-1,028.49%-4.66M
-Change in receivables 603.16%668K-100.89%-446K-382.41%-305K-93.68%6K-15.24%-242K-99.81%95K5,970.95%50.31M114.34%108K-61.85%95K3.67%-210K
-Change in prepaid assets 123.02%195K-193.72%-418K-567.61%-474K523.38%326K2,647.62%577K-247.82%-847K719.44%446K-106.14%-71K93.90%-77K-83.33%21K
-Change in payables and accrued expense 83.42%-574K87.73%-2.3M202.83%1.16M-70.73%485K-47.08%-478K81.68%-3.46M-186.40%-18.7M-105.30%-1.13M26.59%1.66M-527.63%-325K
-Change in other working capital 42.57%-1.22M42.75%-7.65M2.53%-1.7M63.47%-951K30.60%-2.88M56.40%-2.12M-3,614.21%-13.35M-311.11%-1.74M-821.05%-2.6M-900.58%-4.15M
Cash from discontinued investing activities
Operating cash flow 48.56%-5.78M-2,797.45%-28.57M27.51%-6.02M8.08%-5.04M11.24%-6.27M-151.32%-11.24M104.49%1.06M-41.38%-8.3M-13.04%-5.48M-30.39%-7.06M
Investing cash flow
Cash flow from continuing investing activities -100.25%-38K200.63%46.45M290.94%9.74M105.19%2.12M19,851.55%19.16M33,634.78%15.43M-573.67%-46.16M-3,394.52%-5.1M-60,067.65%-40.91M15.65%-97K
Net PPE purchase and sale 79.79%-38K-63.20%-674K-668.75%-91K51.40%-139K-163.92%-256K-308.70%-188K-21.47%-413K110.96%16K-320.59%-286K15.65%-97K
Net investment purchase and sale --0203.01%47.12M292.13%9.83M105.57%2.26M--19.42M--15.61M---45.75M---5.12M---40.63M--0
Cash from discontinued investing activities
Investing cash flow -100.25%-38K200.63%46.45M290.94%9.74M105.19%2.12M19,851.55%19.16M33,634.78%15.43M-573.67%-46.16M-3,394.52%-5.1M-60,067.65%-40.91M15.65%-97K
Financing cash flow
Cash flow from continuing financing activities 1,402,000.00%14.02M293.57%6.42M-110.66%-13K-16.29%807K16,954.55%5.63M-99.81%1K-95.58%1.63M-87.21%122K-74.08%964K-99.71%33K
Net issuance payments of debt 0.00%-13K-68.75%-54K-44.44%-13K-50.00%-12K-128.57%-16K-62.50%-13K-60.00%-32K-28.57%-9K38.46%-8K---7K
Net common stock issuance 37,975.68%14.01M4,929.01%6.59M--0--836K64,422.22%5.79M-126.43%-37K-99.57%131K--0--0-100.11%-9K
Proceeds from stock option exercised by employees 158.82%132K-94.63%88K--0-99.21%8K-72.64%29K-86.61%51K-77.36%1.64M-85.38%142K9.66%1.01M-97.08%106K
Net other financing activities ---112K-87.74%-199K--034.21%-25K--------90.37%-106K90.91%-11K63.11%-38K----
Cash from discontinued financing activities
Financing cash flow 1,402,000.00%14.02M293.57%6.42M-110.66%-13K-16.29%807K16,954.55%5.63M-99.81%1K-95.58%1.63M-87.21%122K-74.08%964K-99.71%33K
Net cash flow
Beginning cash position 201.54%35.99M-78.79%11.94M26.50%32M-51.73%34.45M-79.62%16.02M-78.79%11.94M69.60%56.28M-58.75%25.3M14.15%71.36M38.60%78.61M
Current changes in cash 95.94%8.2M155.92%24.31M127.93%3.71M95.36%-2.11M359.88%18.52M-81.29%4.19M-288.06%-43.47M-162.25%-13.28M-3,695.32%-45.43M-223.65%-7.13M
Effect of exchange rate changes 30.00%-70K71.36%-250K461.54%282K46.37%-340K22.69%-92K-138.10%-100K-4,265.00%-873K-657.14%-78K-7,144.44%-634K-421.62%-119K
End cash Position 175.40%44.12M201.54%35.99M201.54%35.99M26.50%32M-51.73%34.45M-79.62%16.02M-78.79%11.94M-78.79%11.94M-58.75%25.3M14.15%71.36M
Free cash flow 49.07%-5.82M-4,626.32%-29.24M26.27%-6.11M10.23%-5.18M8.87%-6.52M-152.29%-11.43M102.70%646K-37.68%-8.29M-17.29%-5.77M-29.43%-7.16M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg